Recent Healthcare Trends & Transactions

Week of September 13, 2022 | Vol. 11, Issue 37

Industry Snapshot

Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Contract Pharma Contracting & Outsourcing Conference

September 22-23, 2022 - New Brunswick, NJ

Bourne Partners Global Executive Healthcare Summit

October 12, 2022 - Charlotte, NC

BIO Europe

October 24-26, 2022 - Leipzig, Germany

CPHI Worldwide

November 1-3, 2022 - Messe Frankfurt, Germany

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

RECENT TRANSACTIONS

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A TRANSACTIONS

PRIVATE PLACEMENTS

PUBLIC OFFERINGS

TRADING COMPS

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

MARKET REPORTS

Insight Into Healthcare Related Industries

1H 2022 Pharma Services Sector Snapshot

August 2022

Pharma Sector Snapshot 1H 2022

August 2022

Q2 2022 Consumer Health Sector Snapshot

June 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Sell-Side |Pharma Services| Clinical Trial Services Provider

Project Ester

Sell-side |Pharma| OTC Technology and Products Developer

Project Gateway

Sell-Side |Pharma| Generic Pharmaceuticals

Project Jazz

Sell-Side |Pharma Services| Compounding Pharmacy and Pharmacy Service Provider

Project Panther

Sell-Side| CDMO | Consumer Health and Medical Device

Project Power Play

Buy-Side | Specialty Pharma |Branded & Generic Pharmaceuticals

Project S

Sell-side |Pharma Services | Compounding Pharmacy and Telehealth Platform

Project Trident

Buy-Side | Generic Pharma | Manufacturing liquid generics

FEATURED HEADLINES

A Sampling of Industry Headlines

Archimica September 2022 Press Release Expansion of Multi-Purpose Manufacturing Capacity

Archimica - September 5, 2022

Catalent Expands Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities

Catalent - September 6, 2022

Lonza and Touchlight collaborate on end-to-end mRNA offering

Touchlight - September 6, 2022

NextPharma and Takeda announce Future of Pharmaceutical Manufacturing Site in Asker, Norway

Press Release Atlantic - September 6, 2022

Virginia reels in $52.9M for manufacturing as part of government competition

Fierce Pharma - September 6, 2022

Roche snaps up PD-1-focused Good Therapeutics for $250M; 'Sky's the limit' for spinout

Fierce Biotech - September 7, 2022

GSK taps Medable for decentralized clinical trials, patient diversity

Fierce Biotech - September 7, 2022

Company selected to provide range of CDMO services for two new customers

Societal CDMO - September 7, 2022

Stevanato Group and Gerresheimer AG Announce Collaboration on the Development of an Innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry

Stevanto Group - September 7, 2022

Pace Life Sciences Acquires Biopharma Global

Contract Pharma - September 8, 2022

AGC Biologics Partners with Evax

Contract Pharma- September 7, 2022

TANNER NEWS

Rare Rev-inar September 22, 2022

EAPs are compliant pathways that provide critical medicines to patients before the treatments are commercially available in their country. But what does an early access pathway look like? Join Tanner EVP John Lagus and other industry leaders for a multi-stakeholder discussion with opportunities for audience engagement. Register here.

Increasing the efficiency of clinical trials

Tanner EVP Georg Schulz offers his perspective on the trends and challenges affecting clinical trials, including the growing prevalence of digital and decentralized trials and COVID-19 induced supply chain issues. Read more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.